Clinical Trial Update: LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed [Phase 2]

View source ↗

Summary

Phase 2 trial of LC Drug Eluting Bead for unresectable hepatocellular carcinoma completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• LC Drug Eluting Bead

Snippet

Sponsor: University of Pittsburgh | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2016-02-08